Briefing
Urine cell-free DNA multi-omics to detect MRD and predict survival in bladder cancer patients.
Random-forest LOOCV 87% sensitive for residual disease vs surgical pathology.
- Design: Localized bladder cancer
- n: 74
- Assay: ULP-WGS plus uCAPP-Seq